Paper40051146
Antibody-Nanoparticle Conjugates in Therapy: Combining the Best of Two Worlds.
Adhikari A and 1 other. Small, 2025. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Antibody-Nanoparticle Conjugates in Therapy: Combining the Best of Two Worlds. Papers, record 40051146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40051146
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanoparticles | Major topic |
| Antibodies, Monoclonal | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R35 GM148249 | NIGMS NIH HHS | United States | R35GM148249 | PubMed and NIH |
| R35GM148249 | NIGMS NIH HHS | United States | R35GM148249 | PubMed and NIH |
Source NIH RePORTER
References301
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23891990 | Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. | Nanomedicine | 2014 | https://conductscience.org/library/papers/23891990 | PubMed |
| 2 | 28187290 | Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. | Cell | 2017 | https://conductscience.org/library/papers/28187290 | PubMed |
| 3 | 21039191 | Antibody engineering promotes nanomedicine for cancer treatment. | Nanomedicine (Lond) | 2010 | https://conductscience.org/library/papers/21039191 | PubMed |
| 4 | 23670869 | Future of the particle replication in nonwetting templates (PRINT) technology. | Angew Chem Int Ed Engl | 2013 | https://conductscience.org/library/papers/23670869 | PubMed |
| 5 | 33615202 | Dissecting the impact of target-binding kinetics of protein binders on tumor localization. | iScience | 2021 | https://conductscience.org/library/papers/33615202 | PubMed |
| 6 | 20134491 | Optimizing the safety of biologic therapy for IBD. | Nat Rev Gastroenterol Hepatol | 2010 | https://conductscience.org/library/papers/20134491 | PubMed |
| 7 | 38324463 | PD-L1 Immune Checkpoint Targeted Photoactivable Liposomes (iTPALs) Prime the Stroma of Pancreatic Tumors and Promote Self-Delivery. | Adv Healthc Mater | 2024 | https://conductscience.org/library/papers/38324463 | PubMed |
| 8 | 30844256 | pH Impacts the Orientation of Antibody Adsorbed onto Gold Nanoparticles. | Bioconjug Chem | 2019 | https://conductscience.org/library/papers/30844256 | PubMed |
| 9 | 27348241 | Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles. | ACS Appl Mater Interfaces | 2016 | https://conductscience.org/library/papers/27348241 | PubMed |
| 10 | 25305336 | Lessons from patient-derived xenografts for better in vitro modeling of human cancer. | Adv Drug Deliv Rev | 2014 | https://conductscience.org/library/papers/25305336 | PubMed |
| 11 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 12 | 21223986 | A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro. | J Control Release | 2011 | https://conductscience.org/library/papers/21223986 | PubMed |
| 13 | 17069527 | Antibody-directed enzyme prodrug therapy (ADEPT) for cancer. | Expert Rev Anticancer Ther | 2006 | https://conductscience.org/library/papers/17069527 | PubMed |
| 14 | 22493784 | Predictive in vivo animal models and translation to clinical trials. | Drug Discov Today | 2012 | https://conductscience.org/library/papers/22493784 | PubMed |
| 15 | 11144234 | Uptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer. | J Drug Target | 2000 | https://conductscience.org/library/papers/11144234 | PubMed |
| 16 | 39663706 | Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement Activation. | Adv Mater | 2025 | https://conductscience.org/library/papers/39663706 | PubMed |
| 17 | 19664713 | Structure and function of the blood-brain barrier. | Neurobiol Dis | 2010 | https://conductscience.org/library/papers/19664713 | PubMed |
| 18 | 19509221 | Bispecific T-cell engaging antibodies for cancer therapy. | Cancer Res | 2009 | https://conductscience.org/library/papers/19509221 | PubMed |
| 19 | 2384160 | Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. | FEBS Lett | 1990 | https://conductscience.org/library/papers/2384160 | PubMed |
| 20 | 38724718 | Computational design of non-porous pH-responsive antibody nanoparticles. | Nat Struct Mol Biol | 2024 | https://conductscience.org/library/papers/38724718 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42950029 | Nanomaterial-genetics enables near-infrared-driven genetically targeted neuromodulation. | Sci Adv | 2026 | https://conductscience.org/library/papers/42950029 | PubMed |
| 42824429 | Ultrahigh-DAR antibody-drug conjugates: advancing the next generation of targeted therapy. | Antib Ther | 2026 | https://conductscience.org/library/papers/42824429 | PubMed |
| 42700201 | Metal nanoparticles as next-generation therapeutics against antimicrobial resistance: mechanisms, functionalization, and translational potential. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42700201 | PubMed |
| 42588669 | Targeting EGFR Endocytosis and Signaling for Cancer Drug Delivery and Cancer Treatment. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588669 | PubMed |
| 42286319 | Reprogramming immunity: the promise and challenges of CAR T cell therapy in multiple sclerosis. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42286319 | PubMed |
| 42193283 | Functionalized Lipid Nanoparticles for Targeted RNA Delivery in Immune and Inflammatory Diseases. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193283 | PubMed |
| 42079870 | Antibody-drug conjugates for infectious and neglected tropical diseases: chemical design principles, target biology, and translational challenges. | Front Chem | 2026 | https://conductscience.org/library/papers/42079870 | PubMed |
| 42076087 | Surface-Modified Polymeric Nanoparticles for Glioblastoma Therapy: A Review on Targeting Strategies and Delivery of Repurposed Drugs and Off-Label Non-Alkylating Agents. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076087 | PubMed |
| 41853243 | Liposome-mediated gene delivery: A comprehensive review of biophysical parameters, lipid composition and targeting strategies. | ADMET DMPK | 2026 | https://conductscience.org/library/papers/41853243 | PubMed |
| 41834375 | Balancing Multivalent Avidity and Receptor Availability Governs mRNA Delivery by Antibody-Functionalized Lipid Nanoparticles. | Nano Lett | 2026 | https://conductscience.org/library/papers/41834375 | PubMed |
| 41749221 | Engineering integrin αvβ8-targeted extracellular vesicles to deliver BDNF mRNA for motor recovery in spinal cord injury. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41749221 | PubMed |
| 41709436 | Antibody-Antibiotic Conjugates: Mechanisms, Clinical Progress, and Next-Generation Strategies Against Multidrug-Resistant Bacterial Infections. | Microbiologyopen | 2026 | https://conductscience.org/library/papers/41709436 | PubMed |
| 41601298 | Chelation-Controlled Oriented and Irreversible Immobilization of Native Antibodies on Photoreactive Magnetic Nanoparticles. | ACS Appl Bio Mater | 2026 | https://conductscience.org/library/papers/41601298 | PubMed |
| 41560793 | Recent advances in cancer nanomedicine: From smart targeting to personalized therapeutics - pioneering a new era in precision oncology. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41560793 | PubMed |
| 41524227 | Antibody-Empowered Nanomedicine for Precise Biomedical Applications. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41524227 | PubMed |
| 41409587 | Allosteric ligand-driven smart nanoconjugates for mutation-selective EGFR targeting: A precision approach to overcoming tyrosine kinase inhibitor resistance. | Bioimpacts | 2025 | https://conductscience.org/library/papers/41409587 | PubMed |
| 41363830 | Emerging Advances in Nanomedicine for Targeted Cancer Photoimmunotherapy and Photo-Immunometabolic Therapy. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2025 | https://conductscience.org/library/papers/41363830 | PubMed |
| 41184856 | Antibody-drug conjugates in cancer therapy: current landscape, challenges, and future directions. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41184856 | PubMed |
| 41035645 | Cell death mechanisms induced by gold nano-immunoconjugates-mediated photodynamic therapy against human oesophageal cancer stem cells. | Front Immunol | 2025 | https://conductscience.org/library/papers/41035645 | PubMed |
| 41012501 | Strategic and Chemical Advances in Antibody-Drug Conjugates. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012501 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40051146
GET https://conductscience.org/api/papers/v1/40051146/references?page=2